MRI-guided ablation no better than conventional PVI for Atrial Fibrillation
Key Points: DECAAF-1 showed that higher volumes of atrial tissue fibrosis on cardiac... Read more.
ENVISAGE-TAVI AF shows edoxaban noninferior to VKAs in patients with AFib after TAVR.
Key Points: ENVISAGE-TAVI AF is a large, multinational, randomized-control trial investigate the safety and efficacy of edoxaban versus warfarin for those with atrial... Read more.
Finerenone not only slows progression of kidney disease, but prevents cardiovascular events as well: results from FIGARO-DKD
Key Points: Finerenone is a nonsteroidal mineralocorticoid antagonist that has been shown to decrease adverse... Read more.
Haemodynamic Guided Heart Failure Management as a Hospitalization Reduction Strategy – the GUIDE-HF Tria
KEY POINTS: · CardioMEMS, a wireless, battery-free pressure sensor implanted in the pulmonary artery that transmits real-time pressure data, is an established means... Read more.
SMART-MI shows Benefits of Cardiac Monitoring after Myocardial Infarction
KEY POINTS: Implantable Cardioverter Defibrillators (ICDs) are indicated for post-myocardial infarction patients with severely reduced left ventricular systolic... Read more.
Empagliflozin does it again: Results from EMPEROR-PRESERVED
Key Points: Patients with chronic heart failure with preserved ejection fraction (HFpEF, defined here as EF>40%) with or without diabetes were treated with empagliflozin,... Read more.